These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 20002538)
1. Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma. Castoldi E; Simioni P; Tormene D; Rosing J; Hackeng TM J Thromb Haemost; 2010 Feb; 8(2):294-300. PubMed ID: 20002538 [TBL] [Abstract][Full Text] [Related]
2. New functional assays to selectively quantify the activated protein C- and tissue factor pathway inhibitor-cofactor activities of protein S in plasma. Alshaikh NA; Rosing J; Thomassen MCLGD; Castoldi E; Simioni P; Hackeng TM J Thromb Haemost; 2017 May; 15(5):950-960. PubMed ID: 28211163 [TBL] [Abstract][Full Text] [Related]
3. Thrombin generation-based assays to measure the activity of the TFPI-protein S pathway in plasma from normal and protein S-deficient individuals. Maurissen LF; Castoldi E; Simioni P; Rosing J; Hackeng TM J Thromb Haemost; 2010 Apr; 8(4):750-8. PubMed ID: 20088940 [TBL] [Abstract][Full Text] [Related]
4. Decreased tissue factor pathway inhibitor (TFPI)-dependent anticoagulant capacity in patients with cirrhosis who have decreased protein S but normal TFPI plasma levels. Potze W; Arshad F; Adelmeijer J; Blokzijl H; van den Berg AP; Meijers JC; Porte RJ; Lisman T Br J Haematol; 2013 Sep; 162(6):819-26. PubMed ID: 23841464 [TBL] [Abstract][Full Text] [Related]
5. Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives. Harris GM; Stendt CL; Vollenhoven BJ; Gan TE; Tipping PG Am J Hematol; 1999 Mar; 60(3):175-80. PubMed ID: 10072106 [TBL] [Abstract][Full Text] [Related]
6. TFPI-dependent activities of protein S. Peraramelli S; Rosing J; Hackeng TM Thromb Res; 2012 May; 129 Suppl 2():S23-6. PubMed ID: 22425215 [TBL] [Abstract][Full Text] [Related]
7. Protein S is a cofactor for tissue factor pathway inhibitor. Rosing J; Maurissen LF; Tchaikovski SN; Tans G; Hackeng TM Thromb Res; 2008; 122 Suppl 1():S60-3. PubMed ID: 18691502 [TBL] [Abstract][Full Text] [Related]
8. Changes in haemostatic parameters during the menstrual cycle and subsequent use of drospirenone-containing oral contraceptives. Tchaikovski SN; Thomassen MC; Costa SD; Bremme K; Rosing J Thromb Res; 2014 Nov; 134(5):1032-7. PubMed ID: 25260941 [TBL] [Abstract][Full Text] [Related]
9. TFPI resistance related to inherited or acquired protein S deficiency. Tardy-Poncet B; Piot M; Brunet D; Chapelle C; Bonardel M; Mismetti P; Morange P; Tardy B Thromb Res; 2012 Dec; 130(6):925-8. PubMed ID: 23079294 [TBL] [Abstract][Full Text] [Related]
10. Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. Duckers C; Simioni P; Spiezia L; Radu C; Gavasso S; Rosing J; Castoldi E Blood; 2008 Nov; 112(9):3615-23. PubMed ID: 18695002 [TBL] [Abstract][Full Text] [Related]
13. Platelet full length TFPI-α in healthy volunteers is not affected by sex or hormonal use. Winckers K; Thomassen S; Ten Cate H; Hackeng TM PLoS One; 2017; 12(2):e0168273. PubMed ID: 28158181 [TBL] [Abstract][Full Text] [Related]
14. Elevated plasma TFPI activity causes attenuated TF-dependent thrombin generation in early onset preeclampsia. Egan K; O'Connor H; Kevane B; Malone F; Lennon A; Al Zadjali A; Cooley S; Monteith C; Maguire P; Szklanna PB; Allen S; McCallion N; Ní Áinle F Thromb Haemost; 2017 Jul; 117(8):1549-1557. PubMed ID: 28569919 [TBL] [Abstract][Full Text] [Related]
15. New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV-Short. Dahlbäck B; Guo LJ; Zöller B; Tran S J Thromb Haemost; 2019 Apr; 17(4):585-595. PubMed ID: 30740865 [TBL] [Abstract][Full Text] [Related]
16. Compound heterozygous mutations identified in severe type I protein S deficiency impaired the secretion of protein S. Zhou J; Shen W; Gu Y; Li M; Shen W J Clin Pathol; 2020 Jan; 73(1):7-13. PubMed ID: 31422373 [TBL] [Abstract][Full Text] [Related]
17. Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from mixed type I/III families. Castoldi E; Maurissen LF; Tormene D; Spiezia L; Gavasso S; Radu C; Hackeng TM; Rosing J; Simioni P Haematologica; 2010 Apr; ():. PubMed ID: 20378562 [TBL] [Abstract][Full Text] [Related]
18. Plasma free tissue factor pathway inhibitor (TFPI) levels and TF-induced thrombin generation ex vivo in men with low testosterone levels. Agledahl I; Brodin E; Svartberg J; Hansen JB Thromb Haemost; 2009 Mar; 101(3):471-7. PubMed ID: 19277407 [TBL] [Abstract][Full Text] [Related]
19. Resistance to activated protein C in healthy women taking oral contraceptives. Olivieri O; Friso S; Manzato F; Guella A; Bernardi F; Lunghi B; Girelli D; Azzini M; Brocco G; Russo C Br J Haematol; 1995 Oct; 91(2):465-70. PubMed ID: 8547095 [TBL] [Abstract][Full Text] [Related]
20. The Levels of Tissue Factor Pathway Inhibitor in Sepsis Patients Receiving Prophylactic Enoxaparin. Al Otair HA; Abdel Gader AG; Khurshid SM; Alzeer AH; Al Momen AK; Al Shaikh M; Al Gahtani F; Al Aseri ZA; Abdelrazik HA Turk J Haematol; 2016 Jun; 33(2):112-8. PubMed ID: 26377606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]